Last CNY20.80 CNY
Change Today -0.42 / -1.98%
Volume 9.3M
002653 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

xizang haisco pharmaceutic-a (002653) Snapshot

Open
CNY20.95
Previous Close
CNY21.22
Day High
CNY21.18
Day Low
CNY20.55
52 Week High
10/15/13 - CNY24.39
52 Week Low
05/21/14 - CNY16.93
Market Cap
22.5B
Average Volume 10 Days
4.6M
EPS TTM
CNY0.48
Shares Outstanding
1.1B
EX-Date
05/19/14
P/E TM
43.3x
Dividend
CNY0.25
Dividend Yield
1.20%
Current Stock Chart for XIZANG HAISCO PHARMACEUTIC-A (002653)

Related News

No related news articles were found.

xizang haisco pharmaceutic-a (002653) Related Businessweek News

No Related Businessweek News Found

xizang haisco pharmaceutic-a (002653) Details

Xizang Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. It offers capsules, tablets, granules, and bulk drugs in the fields of cardiovascular, liver disease, diabetes, anti-infection, digestive system, hematological system, nervous and mental system, parenteral nutrition, first-aid, antibiotics, and tumor adjuvant applications. The company’s products include invert sugar, sodium fusidate, polyene phosphatidylcholine, and fat-soluble vitamins. It also develops nalmefene hydrochloride, dolasetron mesylate, cefodizime sodium, and compound amino acids. The company was founded in 2000 and is based in Chengdu, China.

Founded in 2000

xizang haisco pharmaceutic-a (002653) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xizang haisco pharmaceutic-a (002653) Key Developments

Xizang Haisco Pharmaceutical Group Co., Ltd. Proposes to Amend Articles of Association

Xizang Haisco Pharmaceutical Group Co., Ltd. announced that at its EGM to be held on September 10, 2014, the shareholders proposed to amend articles of association.

Xizang Haisco Pharmaceutical Group Co., Ltd. to Report First Half, 2014 Results on Aug 22, 2014

Xizang Haisco Pharmaceutical Group Co., Ltd. announced that they will report first half, 2014 results on Aug 22, 2014

Xizang Haisco Pharmaceutical Group Co., Ltd. Implements Final Cash Dividend, Payable on May 19, 2014

Xizang Haisco Pharmaceutical Group Co., Ltd. implemented final cash dividend of CNY 2.50000000 per ten A shares (tax included) for 2013. The record date is May 16, 2014 with payable on May 19, 2014. The ex-date May 19, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002653:CH CNY20.80 CNY -0.42

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 43.8x
Price/Sales 23.4x
Price/Book 13.2x
Price/Cash Flow 43.3x
TEV/Sales 20.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIZANG HAISCO PHARMACEUTIC-A, please visit www.haisco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.